A Randomized Double-Blind Placebo Controlled Trial of Oral Acyclovir in Renal Allograft Recipients

Fifty renal transplant patients were randomized to receive either 800 mg acyclovir by mouth four times daily or identical placebo tablets for prophylaxis of herpes simplex infection. Patients were followed weekly to assess reactivation of herpes simplex, varicella zoster virus, Epstein-Barr virus or...

Full description

Saved in:
Bibliographic Details
Main Authors: Walter F Schlech, Nancy Meagher, Allan D Cohen, Philip Belitsky, AS MacDonald, John C LeBlanc
Format: Article
Language:English
Published: Wiley 1993-01-01
Series:Canadian Journal of Infectious Diseases
Online Access:http://dx.doi.org/10.1155/1993/845236
Tags: Add Tag
No Tags, Be the first to tag this record!